SignatureFD’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.7K Buy
273
+231
+550% +$13.1K ﹤0.01% 2373
2026
Q1
$2.7K Sell
42
-49
-54% -$4.47K ﹤0.01% 2974
2025
Q4
$11.8K Buy
91
+49
+117% +$6.72K ﹤0.01% 2354
2025
Q3
$4.53K Hold
42
﹤0.01% 2712
2025
Q2
$3.88K Sell
42
-27
-39% -$2.12K ﹤0.01% 2684
2025
Q1
$6.12K Buy
69
+7
+11% +$607 ﹤0.01% 2528
2024
Q4
$4.76K Buy
62
+20
+48% +$1.4K ﹤0.01% 2625
2024
Q3
$1.78K Hold
42
﹤0.01% 2863
2024
Q2
$1.1K Hold
42
﹤0.01% 2885
2024
Q1
$383 Hold
42
﹤0.01% 3055
2023
Q4
$116 Hold
42
﹤0.01% 3082
2023
Q3
$153 Sell
42
-400
-90% -$2.19K ﹤0.01% 3118
2023
Q2
$2.63K Buy
442
+400
+952% +$3.17K ﹤0.01% 2724
2023
Q1
$502 Hold
42
﹤0.01% 3099
2022
Q4
$363 Hold
42
﹤0.01% 3143
2022
Q3
$1K Buy
42
+4
+11% +$183 ﹤0.01% 3051
2022
Q2
$2K Buy
+38
New +$2.58K ﹤0.01% 2818

Other funds holding WGS

SignatureFD's WGS Position: Q2 2026 in Review

SignatureFD increased its GeneDx Holdings (WGS) stake by 550% in Q2 2026, buying an estimated $13.1K and bringing the position to 273 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2373.

SignatureFD first reported a position in WGS in Q2 2022 and has held it in 17 quarters since. 25 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • SignatureFD held 273 shares of GeneDx Holdings worth $18.7K as of Q2 2026.
  • SignatureFD bought 231 GeneDx Holdings shares in Q2 2026, an estimated $13.1K.
  • GeneDx Holdings made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2373 holding.
  • SignatureFD first reported a position in GeneDx Holdings in Q2 2022 and has held it in 17 quarters since.
  • 25 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.